Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zeymer Uwe, Ludman Peter, Danchin Nicolas, Kala Petr, Laroche Cécile, Sadeghi Masoumeh, Caporale Roberto, Shaheen Sameh Mohamed, Legutko Jacek, Iakobsishvili Zaza, Alhabib Khalid F, Motovska Zuzana, Studencan Martin, Mimoso Jorge, Becker David, Alexopoulos Dimitrios, Kereseselidze Zviad, Stojkovic Sinisa, Zelveian Parounak, Goda Artan, Mirrakhimov Erkin, Bajraktari Gani, Al-Farhan Hasan, Šerpytis Pranas, Raungaard Bent, Marandi Toomas, Moore Alice May, Quinn Martin, Karjalainen Pasi Paavo, Tatu-Chitolu Gabriel, Gale Chris P, Maggioni Aldo P, Weidinger Franz, ACVC EAPCI EORP ACS STEMI investigators group of the ESC
Аннотация
METHODS AND RESULTS: Prospective cohort (EURObservational Research Programme STEMI Registry) of hospitalized STEMI patients with symptom onset <24 h in 196 centres across 29 countries. A total of 11 462 patients were enrolled, for whom primary percutaneous coronary intervention (PCI) (total cohort frequency: 72.2%, country frequency range 0-100%), fibrinolysis (18.8%; 0-100%), and no reperfusion therapy (9.0%; 0-75%) were performed. Corresponding in-hospital mortality rates from any cause were 3.1%, 4.4%, and 14.1% and overall mortality was 4.4% (country range 2.5-5.9%). Achievement of quality indicators for reperfusion was reported for 92.7% (region range 84.8-97.5%) for the performance of reperfusion therapy of all patients with STEMI <12 h and 54.4% (region range 37.1-70.1%) for timely reperfusion.
CONCLUSIONS: The use of reperfusion therapy for STEMI in the ESC member and affiliated countries was high. Primary PCI was the most frequently used treatment and associated total in-hospital mortality was below 5%. However, there was geographic variation in the use of primary PCI, which was associated with differences in in-hospital mortality.